Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial
Kathryn Coyle, Doug Coyle, Isabelle Nault, Ratika Parkash, Jeffrey S. Healey, Christopher J. Gray, Martin J. Gardner, Laurence D. Sterns, Vidal Essebag, Tomasz Hruczkowski, Louis Blier, George A. Wells, Anthony S.L. Tang, William G. Stevenson, John L. Sapp
Profundice en los temas de investigación de 'Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial'. En conjunto forman una huella única.